Outcomes in Systemic Sclerosis-Associated Interstitial Lung Disease Based on Serological Profiles: Focus on Anti-Centromere and Anti-RNA Polymerase III Antibodies
Related Posts
Zhou FF, Essien UR, Souza JM, Sarkisian CA, Damberg CL, Landon BE, Mafi JN. Disparities in Early Lecanemab Uptake Among US Medicare Beneficiaries. JAMA Netw[...]
Higashi RT, Thakur B, Repasky EC, Casillas A, Steitz BD, Hogan TP, Lehmann CU, Peterson ED, Navar AM, Turer RW. Digital Health Technology Use Among[...]
Nikitas J, Ballas LK, Romero T, Lynch C, Ma TM, Valle LF, Sachdeva A, Chong N, Basehart V, Franco A, Reiter R, Saigal C, Chamie[...]